Project Grant R44HL147825
Award Date 1/2/20
Completion Date 3/31/24
Dollars Obligated $5.3M
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Fremont, CA 94539, USA
Similar Awards
- This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I project under CFDA 47.084 - NSF Technology, Innovation, and Partnerships provides $275,000 to Medfree Inc., a minority-owned small business, to develop a novel, transcatheter device and procedure for the minimally invasive surgical revision and repair of the tricuspid valve. The project aims to address the significant unmet need for percutaneous treatment options for the over 1.6 million U.S. patients...
- This $250,000 National Science Foundation Engineering (47.041) Project Grant funds the development of a novel annuloplasty ring prototype for minimally invasive mitral valve repair. North Carolina State University will lead an interdisciplinary team to design, 3D print, and test ring structures using magnets for catheter-guided magnetic assembly within pig hearts and tissue phantoms. The compact ring design aims to enable percutaneous delivery and diameter reduction through catheters to...
- Federal Grant Award Summary Link Medical LLC received a $596,736 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2025, with completion targeted for December 31, 2026. The award funds Phase I development of a novel catheter-based device designed to treat functional mitral valve regurgitation—a condition projected to affect four million Americans by 2030. Link Medical's innovative...
- The National Science Foundation (NSF) has awarded a $455,718 Faculty Early Career Development (CAREER) Project Grant to Marquette University to develop a living, tissue-engineered heart valve substitute capable of growing with child recipients of congenital heart valve defects. The 5-year project, funded under the NSF Engineering program (CFDA 47.041), aims to create a durable, hydrodynamically functional heart valve using an origami-inspired design and patient-derived cells that can self-repair...
- The National Institutes of Health's National Heart, Lung and Blood Institute awarded Fluidform Inc. a $766,107 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) from April 1, 2021 to March 31, 2022. The grant funds the development of an advanced bioprosthetic collagen heart valve using 3D printing techniques to recreate the collagen fiber architecture and mechanical properties of native heart valve leaflets. Fluidform will collaborate with Carnegie Mellon...
- Velakor Biotherapeutics, Inc. received a $2,095,748 Phase II SBIR (Small Business Innovation Research) Project Grant award from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 15, 2025, through September 11, 2026. The company is developing CAM-6019, a recombinant human agrin (rhAgrin) therapeutic candidate designed to address heart failure with reduced ejection fraction (HFrEF) in patients who currently lack...
- Percassist Inc. received a $663,129 Project Grant award from the National Heart Lung and Blood Institute of the Department of Health and Human Services. The award was made under the Cardiovascular Diseases Research program (CFDA 93.837), which supports heart and vascular research. The grant funds the development of a percutaneous ventricular assist device for chronic heart failure patients. Specifically, Percassist will design and test a balloon catheter implant that can be delivered minimally...
- Venarum Medical LLC received a $255,619 Project Grant award from the National Science Foundation on August 15, 2021 to support research and development activities concluding on May 31, 2022. The funding was provided through the NSF's Engineering program (CFDA #47.041), which aims to improve quality of life and economic strength through engineering innovation and excellence. Specifically, the grant supports Venarum Medical's "SBIR PHASE I: INTEGRATED MANUFACTURING OF ARTIFICIAL VALVES FOR...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Peca Labs Inc. a Project Grant of $306,102 under the Cardiovascular Diseases Research program (CFDA 93.837) for the period of August 1, 2025 through July 31, 2026. The award supports the development and testing of a novel fully-polymeric mitral valve constructed from a patented fluoropolymer formulation designed to combine the beneficial characteristics of both biologic and mechanical heart...
- Corveus Medical, Inc. was awarded a $255,841 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an extravascular bipolar catheter for targeted nerve ablation with minimal collateral damage to surrounding tissues. The grant aims to support the design and prototyping of a minimally invasive, catheter-delivered venous procedure for performing extravascular greater splanchnic nerve ablation. The proposed catheter...